ENHANCING HORMONAL THERAPY FOR BREAST CANCER BY COMBINATION WITH A WELL-KNOWN APPROVED PHARMACEUTICAL WITH LITTLE TOXICITY

Regents Of The University Of California, San Francisco, The

Investigators